Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)
CNY 18.83
(1.4%)
CNY 18.83
(1.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 329.42 Million | 200.63 Million | 158.7 Million | 172.48 Million | 149.29 Million | 64.45 Million |
| Net Income | 226.67 Million | 209.6 Million | 172.22 Million | 135.11 Million | 105.14 Million | 91.66 Million |
| Depreciation & Amortization | 47.34 Million | 36.03 Million | 36.91 Million | 15.95 Million | 14.95 Million | 13.77 Million |
| Deferred income taxes | 3.26 Million | -1.69 Million | -2.48 Million | 972.17 Thousand | -724.07 Thousand | -217.1 Thousand |
| Stock-based compensation | 24.24 Million | - | - | - | - | - |
| Change in working capital | -65.2 Million | -19.4 Million | -45.55 Million | 18.96 Million | 26.48 Million | -41.35 Million |
| Other non-cash items | 287.31 Million | -30.75 Million | -4.88 Million | 2.45 Million | 2.71 Million | 370.36 Thousand |
| Investing Cash Flow | -440.6 Million | -201.8 Million | -191.87 Million | -56.18 Million | -43.79 Million | -6.18 Million |
| Investments in PPE | -197.53 Million | -246.42 Million | -186.94 Million | -56.19 Million | -43.9 Million | -29.15 Million |
| Acquisitions | -209.23 Million | 333.68 Thousand | 266.54 Thousand | 11.47 Thousand | 105.75 Thousand | 64.29 Thousand |
| Investment purchases | -795 Million | -940.02 Million | -1.61 Billion | - | - | - |
| Sales/Maturities of investments | 759 Million | 984.3 Million | 1.6 Billion | - | - | 22.9 Million |
| Other Investing Activities | 2.16 Million | 1.30 | 1.52 | -56.19 Million | 0.80 | 64.3 Thousand |
| Financing Cash Flow | 36.62 Million | -47.94 Million | -58.49 Million | 408.44 Million | -25.79 Million | -5.27 Million |
| Debt repayment | -41.99 Million | -10.2 Million | -12.17 Million | -24 Million | -35 Million | -80 Million |
| Dividends payments | -61.23 Million | -64.84 Million | -46.32 Million | -27.79 Million | -20.84 Million | -22.4 Million |
| Common Stock Repurchased | - | - | - | - | 3.5 Million | - |
| Common Stock Issuance | - | - | - | - | -3.5 Million | - |
| Other Financing Activities | 65.98 Million | 27.1 Million | -0.09 | 460.51 Million | 31.21 Million | 97.12 Million |
| Accounts receivables | -211.48 Million | -94.2 Million | -29.57 Million | -37.61 Million | -9.66 Million | -76.95 Million |
| Accounts payables | 175.7 Million | 253.58 Million | -15.46 Million | 71.36 Million | 48.67 Million | 49.01 Million |
| Inventory | -39.49 Million | -177.09 Million | 1.97 Million | -15.75 Million | -11.8 Million | -13.19 Million |
| Other working capital | 10.07 Million | -1.69 Million | -2.48 Million | 972.17 Thousand | -724.07 Thousand | -28.16 Million |
| Cash at beginning of period | 642.57 Million | 625.94 Million | 717.79 Million | 193.53 Million | 113.72 Million | 60.7 Million |
| Cash at end of period | 502.92 Million | 577.22 Million | 625.94 Million | 717.79 Million | 193.53 Million | 113.72 Million |
| Capital Expenditure | -197.53 Million | -246.42 Million | -186.94 Million | -56.19 Million | -43.9 Million | -29.15 Million |
| Effect of forex changes on cash | 43.34 Thousand | 403.04 Thousand | -180.91 Thousand | -487.75 Thousand | 100.94 Thousand | 40.91 Thousand |
| Net cash flow / Change in cash | -139.65 Million | -48.71 Million | -91.85 Million | 524.25 Million | 79.81 Million | 53.02 Million |
| Free Cash Flow | 131.88 Million | -45.78 Million | -28.24 Million | 116.29 Million | 105.39 Million | 35.29 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 41.54 Million | 47.05 Million | 30.37 Million | 226.67 Million | 55.29 Million | 40.24 Million |
| Depreciation & Amortization | - | 19.26 Million | 19.26 Million | 47.34 Million | 13.57 Million | -18.65 Million |
| Deferred income taxes | - | - | - | 3.26 Million | - | - |
| Stock-based compensation | - | 9.27 Million | - | 24.24 Million | 24.24 Million | - |
| Change in working capital | - | -84.61 Million | - | -65.2 Million | -240.9 Million | -357.17 Million |
| Other non-cash items | 10.22 Million | 36.19 Million | -14.88 Million | 287.31 Million | 132.59 Million | 337.91 Million |
| Investing Cash Flow | -26.34 Million | 115.22 Million | -328.42 Million | -440.6 Million | 133.62 Million | -37.97 Million |
| Investments in PPE | -12.93 Million | -46.54 Million | -48.66 Million | -197.53 Million | -54.55 Million | -29.95 Million |
| Acquisitions | -2941.42 | -24.44 Million | - | -209.23 Million | 11.85 Million | -221.09 Million |
| Investment purchases | -113.41 Million | 11.22 Million | -281.22 Million | -795 Million | -250 Million | -140 Million |
| Sales/Maturities of investments | 100 Million | 176.75 Million | 1.45 Million | 759 Million | 399 Million | 353.07 Million |
| Other Investing Activities | - | 188 Million | -279.76 Million | 2.16 Million | 27.32 Million | 0.99 |
| Financing Cash Flow | 26.66 Million | -98.86 Million | -2.43 Million | 36.62 Million | -7.92 Million | 1.81 Million |
| Debt repayment | - | - | - | -41.99 Million | - | - |
| Dividends payments | - | -79.82 Million | - | -61.23 Million | -61.23 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 26.66 Million | -13.7 Million | -2.43 Million | 65.98 Million | 63.43 Million | 1.81 Million |
| Accounts receivables | - | -107.5 Million | - | -211.48 Million | -211.48 Million | -170.78 Million |
| Accounts payables | - | - | - | 175.7 Million | - | 11.44 Million |
| Inventory | - | 12.72 Million | - | -39.49 Million | -39.49 Million | -186.39 Million |
| Other working capital | - | 10.16 Million | - | 10.07 Million | 10.07 Million | -11.44 Million |
| Cash at beginning of period | 267.76 Million | 187.74 Million | 502.72 Million | 642.57 Million | 202.7 Million | 236.53 Million |
| Cash at end of period | 319.78 Million | 267.76 Million | 187.35 Million | 502.92 Million | 502.92 Million | 202.7 Million |
| Capital Expenditure | -12.93 Million | -46.54 Million | -48.66 Million | -197.53 Million | -54.55 Million | -29.95 Million |
| Effect of forex changes on cash | - | -228.31 | 1614.03 | 43.34 Thousand | -1945.58 | -628.73 |
| Net cash flow / Change in cash | 52.01 Million | 80.02 Million | -315.37 Million | -139.65 Million | 300.22 Million | -33.83 Million |
| Free Cash Flow | 38.84 Million | 17.44 Million | -33.17 Million | 131.88 Million | 119.75 Million | -27.62 Million |
6024
267270
OEWA
RWMI
014825
GHBWF